ZTS

Zoetis Inc
NYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$31.95B
P/E Ratio
12.60
EPS
$6.15
Beta
0.75
52W High
$157.46
52W Low
$70.98
50-Day MA
$77.18
200-Day MA
$111.44
Dividend Yield
2.64%
Profit Margin
28.00%
Forward P/E
11.25
PEG Ratio
1.84

About Zoetis Inc

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$9.53B
Gross Profit (TTM)$6.85B
EBITDA$4.07B
Operating Margin36.60%
Return on Equity67.70%
Return on Assets15.50%
Revenue/Share (TTM)$21.81
Book Value$7.84
Price-to-Book9.97
Price-to-Sales (TTM)3.41
EV/Revenue4.149
EV/EBITDA9.74
Quarterly Earnings Growth (YoY)6.00%
Quarterly Revenue Growth (YoY)2.90%
Shares Outstanding$419.23M
Float$418.38M
% Insiders0.15%
% Institutions101.44%

Historical Volatility

HV 10-Day
22.22%
HV 20-Day
23.30%
HV 30-Day
28.22%
HV 60-Day
59.51%
HV Rank
61.9%

Volatility is currently contracting

Analyst Ratings

Consensus ($111.94 target)
3
Strong Buy
8
Buy
9
Hold

Latest News

ZTS DEADLINE TODAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Zoetis Inc. Investors to Secure Counsel Before Important July 27 Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp7/27/2026Neutral
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).

GlobeNewsWire7/27/2026Neutral
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, July 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). IF YOU SUFFERED A LOSS ON YOUR ZOETIS INVESTMENTS, CLICK  HERE  BEFORE JULY 27, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

PRNewsWire7/24/2026Neutral
Zoetis: Sentiment Keeps Winning As Fundamentals Improve

Zoetis Inc. trades at a 45% discount to fair value despite resilient fundamentals and long-term growth prospects. ZTS's Q1 2026 saw 2.9% revenue growth and 8.5% adjusted EPS growth, with livestock offsetting domestic pet care weakness. Forward P/E of 10.5 is well below its 10-year average; a fair value multiple of 19 is justified given a 7.5% EPS growth consensus.

Seeking Alpha7/24/2026Positive
ZTS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Zoetis Inc. Investors to Secure Counsel Before Important July 27 Deadline in Securities Class Action - ZTS

New York, New York--(Newsfile Corp. - July 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Newsfile Corp7/24/2026Neutral
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).

GlobeNewsWire7/23/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ZTS and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026